Company profile
Averna Therapeutics
The future of genomic medicines
- Industry
- Biotechnology Research
- Employees
- 63
Averna Therapeutics company summary
Averna Therapeutics is a company in the Biotechnology Research industry. On LinkedIn the company has around 63 employees.
What technology does Averna Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Averna Therapeutics
Averna Therapeutics is a biotechnology company developing ribonucleic acid (RNA) and lipid nanoparticle (LNP)-based genomic medicines to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions. Our proprietary technology is based on a natural system and inserts therapeutic genetic instructions into “safe harbor” sites in the genome – genomic regions that allow stable gene integration without disrupting normal cell function. Because our medicines are encoded in RNA, they can be delivered using validated, non-viral delivery platforms that are safe, efficient, scalable, and cost-effective, and that allow redosing to effect with a curative intent. Follow us on LinkedIn and stay in touch as we seek to advance develop RNA/LNP-based genomic medicines that deliver meaningful solutions for patients!
Compare companies similar to Averna Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Averna Therapeutics avernatx.com | Biotechnology Research | 63 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Averna Therapeutics
What does Averna Therapeutics do?
Averna Therapeutics is a biotechnology company developing ribonucleic acid (RNA) and lipid nanoparticle (LNP)-based genomic medicines to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions. Our proprietary technology is based on a natural system and inserts therapeutic genetic instructions into “safe harbor” sites in the genome – genomic regions that allow stable gene integration without disrupting normal cell function. Because our medicines are encoded in RNA, they can be delivered using validated, non-viral delivery platforms that are safe, efficient, scalable, and cost-effective, and that allow redosing to effect with a curative intent. Follow us on LinkedIn and stay in touch as we seek to advance develop RNA/LNP-based genomic medicines that deliver meaningful solutions for patients!
How many employees does Averna Therapeutics have?
Averna Therapeutics has around 63 employees on LinkedIn.
Build a lead list from companies like Averna Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.